Studies forecast that the market for artificial intelligence in healthcare will grow 1000% between 2022 and 2029. This impact will likely touch on all sectors, including the drug development process. (1)
If you’re keen on the breakthroughs that are largely due to AI in drug discovery and development, you’ve come to the right guide. Here are five you need to know:
1. Accelerated Drug Discovery
The average drug development process takes over a decade and incurs billions of dollars. While many medical experts say it’s still too early to call, AI has already shown incredible potential to shorten this timeframe. In one case, an AI company managed to advance a drug candidate into a pre-clinical trial in 18 months, something that would have taken four to six years. (2)(3)
Thanks to machine learning capabilities, pharmaceutical companies can now train the AI models to recognize patterns in molecular structures. The AI predicts which compounds might interact effectively with certain biological targets. There’s a ripple effect here: faster discovery means quicker access to life-saving drugs for patients who need them most.
If this interests you, explore tools showing proof of AI accelerating drug discovery and development and join the new revolution in healthcare. Do your research and go with what best suits your research needs.
2. Target Identification and Validation
The drug discovery process begins with identifying the right target, which could be a protein or gene linked to a specific disease. Traditionally, figuring out these targets was slow and expensive, and scientists had to rely on limited data. However, large language models today can comb through vast amounts of genomic, proteomic, and clinical data and settle on exactly where a drug should focus its efforts.
Alzheimer’s disease is a great beneficiary of this process, but it is by no means the only one. Researchers have struggled for years to understand its exact causes and predict its progression. Already, AI is unveiling new insights into the exact causes and giving insights into how future clinical trials can combat it.
Validation is equally important. Before proceeding, scientists need proof that their chosen target is relevant to the disease. AI can simulate how changes in the target affect the body. If tweaking a particular protein leads to improvements in virtual models, it strengthens confidence in pursuing that path.
3. Generative AI for Molecule Design
Once scientists have identified the target, their focus shifts to designing a molecule that interacts perfectly with it. These generative models provide avenues for this to actually work.
AI uses machine learning algorithms to sketch out molecular structures that have the right properties, like being effective against the target while avoiding harmful side effects. What’s even better, studies show that molecules discovered through AI have an 80-90% success rate in phase one. (4)
Another benefit of generative AI is flexibility. Scientists could use this tech to come up with a molecule that looks good, but then it ends up being unstable in the human body. AI can tweak the design until it finds something more stable, making sure drug safety is at the forefront of the research process.
4. Predicting Drug Toxicity and Side Effects
So, you’ve done your work and have gotten a promising molecule that seems to hit your target perfectly. But you have questions about whether it has serious side effects or, worse, if it’s toxic to the body.
Traditionally, toxicity prediction involved extensive animal testing and long-term studies. These methods still have their place in modern science; however, they’re often slow and sometimes inaccurate when applied to humans.
AI can analyze vast datasets of past drugs and their outcomes. Over time, it learns patterns like which chemical structures tend to cause liver damage or trigger allergic reactions. When a new molecule comes along, the AI uses its predictive toxicology capabilities to outline potential risks.
One saving grace of artificial intelligence is that it doesn’t do blanket dismissals. It goes further to explain why a molecule might be toxic. It could highlight specific parts of the structure that have the potential to cause trouble. That way, you know exactly what to change to improve drug efficacy rates and meet the regulatory frameworks in place to safeguard the process.
5. Repurposing Existing Drugs
AI makes drug repurposing easier. Instead of starting from scratch every time, scientists can reuse medicines already in the drug database.
An AI model scans this real-world data to find connections others might miss. This could be anything, from a heart medication that also inhibits cancer cell growth, or an antiviral drug that could treat autoimmune disorders.
Closing Thoughts
AI has indeed transformed drug discovery and development. This impact on the medical field and human life in general will echo for eons to come. If you’d like to be a part of this development, consider researching the different artificial intelligence solutions on offer and choosing what works for your research needs.
References
- “Use of Artificial Intelligence in Drug Development”, Source: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2819343
- “AI-Driven Drug Discovery: A Comprehensive Review”, Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC12177741
- “From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes”, Source: https://www.mdpi.com/1424-8247/18/7/981
- “How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons”, Source: https://www.sciencedirect.com/science/article/pii/S135964462400134X